Zhengrong Cui
- Pharmaceutical Science top 0.1%
- Advanced Drug Delivery Systems 20
- Advancements in Transdermal Drug Delivery 13
- Immunology top 1%
- Immunotherapy and Immune Responses 50
- Immune Response and Inflammation 17
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 20
- Molecular Biology top 2%
- RNA Interference and Gene Delivery 44
- Protein purification and stability 12
- Infectious Diseases top 2%
-
- Inhalation and Respiratory Drug Delivery 17
- Co-authors
- Russell J. MumperBrian R. SloatRobert O. WilliamsMoses O. OyewumiAmit KumarHaiyue XuHannah L. O’MaryYoussef W. Naguib
- Journals
- International Journal of Pharmaceutics (37 papers)Journal of Controlled Release (14 papers)Pharmaceutical Research (11 papers)
- Partner nations
- United StatesChinaEgypt
In The Last Decade
Zhengrong Cui
161 papers receiving 5.9k citations
Peers
Comparison fields: 5 of 161
- Pharmaceutical Science 1.3k
- Immunology 2.0k
- Biomaterials 1.1k
- Molecular Biology 2.6k
- Infectious Diseases 604
Countries citing papers authored by Zhengrong Cui
This map shows the geographic impact of Zhengrong Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengrong Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengrong Cui more than expected).
Fields of papers citing papers by Zhengrong Cui
This network shows the impact of papers produced by Zhengrong Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengrong Cui. The network helps show where Zhengrong Cui may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhengrong Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 10 | |
| 8 | 2023 | 10 | |
| 9 | 2023 | 10 | |
| 10 | 2023 | 14 | |
| 11 | 2022 | 17 | |
| 12 | 2022 | 18 | |
| 13 | 2022 | 8 | |
| 14 | 2021 | 3 | |
| 15 | 2021 | 3 | |
| 16 | 2020 | 94 | |
| 17 | 2020 | 13 | |
| 18 | 2019 | 38 | |
| 19 | 2017 | 15 | |
| 20 | 2017 | 47 |
About Zhengrong Cui
Zhengrong Cui is a scholar working on Pharmaceutical Science, Immunology, Biomaterials, Molecular Biology and Dermatology, having authored 163 papers that have together received 6.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (50 papers), RNA Interference and Gene Delivery (44 papers), Advanced Drug Delivery Systems (20 papers), Nanoparticle-Based Drug Delivery (20 papers), Inhalation and Respiratory Drug Delivery (17 papers), Immune Response and Inflammation (17 papers), Advancements in Transdermal Drug Delivery (13 papers) and Protein purification and stability (12 papers). The work is most often cited by research in Pharmaceutical Science (1.3k citations), Immunology (2.0k citations), Biomaterials (1.1k citations), Molecular Biology (2.6k citations) and Infectious Diseases (604 citations). Zhengrong Cui has collaborated with scholars based in United States, China and Egypt. Frequent co-authors include Russell J. Mumper, Brian R. Sloat, Robert O. Williams, Moses O. Oyewumi, Amit Kumar, Haiyue Xu, Hannah L. O’Mary, Youssef W. Naguib, Xinran Li and Abdulaziz M. Aldayel. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Controlled Release, Pharmaceutical Research, Molecular Pharmaceutics and AAPS PharmSciTech.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.